📋 Clinical Overview

A fixed-dose combination (FDC) of an angiotensin II receptor blocker (ARB) and an angiotensin-converting enzyme inhibitor (ACEI) used for the management of hypertension and heart failure. This dual blockade of the renin-angiotensin-aldosterone system (RAAS) provides synergistic antihypertensive and cardioprotective effects, often used when monotherapy is insufficient. It is a Schedule H drug in India.

💊 Dosage & Administration

Adult: One tablet (Valsartan 80mg + Ramipril 2.5mg) once daily. Titrate based on response and tolerability. Maximum: Valsartan 320mg + Ramipril 10mg daily, typically as separate titrated components before switching to equivalent FDC.

Note: Take orally once daily, with or without food, but consistency is advised (preferably without food for more consistent valsartan absorption). Swallow whole with a glass of water. Do not crush or chew. Monitor BP regularly.

⚠️ Contraindications

Hypersensitivity to valsartan, ramipril, or any component; other ACEIs/ARBs causing angioedema.
History of angioedema related to previous ACEI or ARB therapy.
Pregnancy (2nd and 3rd trimesters) and women planning pregnancy.
Concomitant use with Aliskiren in patients with diabetes or renal impairment (GFR <60 ml/min).
Bilateral renal artery stenosis or stenosis in a solitary kidney.
Severe hepatic impairment, cirrhosis, biliary obstruction.

🔬 Mechanism of Action

Provides dual blockade of the Renin-Angiotensin-Aldosterone System (RAAS). Ramipril inhibits the Angiotensin Converting Enzyme (ACE), preventing conversion of angiotensin I to angiotensin II and decreasing breakdown of bradykinin. Valsartan selectively blocks the AT1 receptor, through which angiotensin II exerts its vasoconstrictive, aldosterone-secreting, and pro-fibrotic effects. This results in more complete RAAS suppression than either drug alone.

🤕 Side Effects

Dizziness
Headache
Fatigue
Persistent dry cough (due to ramipril)
Hyperkalemia (mild)
Hypotension (especially initial doses)
Increased blood urea nitrogen (BUN)/serum creatinine

🤰 Special Populations

Pregnancy: CONTRANDICATED in second and third trimesters (Pregnancy Category D). Can cause fetal injury and death, oligohydramnios, fetal lung hypoplasia, skeletal deformities. Discontinue immediately if pregnancy is detected.

Driving: May cause dizziness, lightheadedness, or fatigue, especially during initiation. Patients should not drive or operate machinery until their individual response is known.

🔄 Drug Interactions

Potassium supplements / Salt substitutes (high K+)	Increased risk of severe hyperkalemia.	Major
Potassium-sparing diuretics (Spironolactone, Eplerenone, Amiloride)	Additive risk of hyperkalemia.	Major
Other RAAS agents (Aliskiren, other ACEIs, ARBs)	Increased risk of hypotension, hyperkalemia, renal impairment.	Major
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) e.g., Ibuprofen, Diclofenac	Reduced antihypertensive effect; increased risk of renal impairment.	Moderate
Diuretics (especially loop and thiazide)	Potentiated hypotensive effect, especially first dose.	Moderate
Lithium	Increased serum lithium levels and toxicity risk.	Major
Antidiabetics (Insulin, Sulfonylureas)	Enhanced hypoglycemic effect.	Moderate
Gold injections (Sodium aurothiomalate)	Increased risk of nitritoid reactions (flushing, nausea).	Moderate

🔁 Alternatives to Tribenzor R

Same composition (Valsartan (80mg) + Ramipril (2.5mg)), different brands:

Valentra R Valace R Valzaar R